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ABSTRACT
PREOPERATIVE FLUID THERAPY TO DECREASE POSTOPERATIVE NAUSEA
AND VOMITTING IN HIGH RISK POPULATIONS: PRACTICE CHANGE
OUTCOMES
by Brandi Scarbrough Carmichael
December 2017
Postoperative nausea and vomiting (PONV) continues to be a negative
complication that impacts patient satisfaction and potentiates unfavorable patient
outcomes. Certified Registered Nurse Anesthetists (CRNA) are in a unique position to
help alleviate this problem. However, CRNAs must be vigilant in utilizing evidencebased practices that decrease PONV and identifying patients who have increased risk
factors for developing PONV.
For this doctoral project, an educational in-service on the use of preoperative fluid
therapy to decrease PONV in high risk populations was held with participating CRNAs.
This doctoral project’s main purpose was to evaluate CRNAs’ willingness to make a
practice change after participating in the educational in-service. Also, the in-service
increased the CRNAs’ knowledge on how to recognize patients that are at increased risk
for developing PONV. Before the educational in-service was held, an informal needs
assessment was conducted at the chosen facility. The needs assessment revealed that
CRNAs as well as post-anesthesia care unit (PACU) nurses were still routinely treating
PONV.
Participating CRNAs completed two questionnaires. The first questionnaire was
administered before an educational in-service and the second questionnaire was
ii

administered 2 weeks later. A total of 18 CRNAs participated in the educational inservice and completed both questionnaires. Descriptive statistics was utilized to analyze
the data gathered from the questionnaires.
Before the educational in-service was held, only 5 out of 18 (27.8%) participants
indicated they currently used preoperative fluid therapy to decrease PONV. Two weeks
after the educational in-service was held, 18 out of 18 (100%) participants indicated the
educational in-service influenced their decision to use preoperative fluid therapy in their
plan of care. Although the amount of times preoperative fluid therapy was used varied
among the CRNAs, all 18 participants utilized preoperative fluid therapy in the 2-week
time frame.
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CHAPTER I – INTRODUCTION
Background and Significance
Postoperative nausea and vomiting (PONV) is a major concern for all providers
caring for patients in the surgery setting. PONV has been linked to negative
complications, such as extra time spent in the post-anesthesia care unit (PACU), extended
patient stay, patient discontent, increased hospital expenses, and morbidity (Lambert,
Wakim, & Lambert, 2009). Though considerable research has been done on evidencebased ways to eradicate this complication, it frequently occurs anyway. For instance, “the
overall incidence of PONV for all surgeries has been estimated to be 25% to 30% and up
to 70% in high-risk groups” (Lambert et al., 2009, p. 110). Patients at a higher risk for
PONV include: nonsmokers, women, people who have had motion-sickness or PONV in
the past, and opioids given postoperatively (Yavux et al., 2014).
The use of general anesthesia is constantly evolving and improving to achieve
better anesthesia outcomes for patient populations. The use of multimodal drug
approaches to prevent PONV has become a customary anesthesia practice. Examples
include: (a) patient controlled antiemetics, (b) oxygen use, (c) pain management and
prevention, and (d) antiemetic administration. Common antiemetic drugs used are
sedatives, anxiolytics, antimuscarincis, corticosteroid, antagonists, and providing
adequate hydration (Yavux et al., 2014).
Problem Statement/ Needs Assessment
Though some patients have no risk factors for PONV, they may experience
PONV after surgery. While there are commonly used antiemetic medications, these drugs
can have some safety concerns, particularly their “effect on the ECG with prolongation of
1

the QTc interval by butyrohenones and first-generation 5-HT3 receptor antagonist class
of antiemetics” (Kovac, 2013, p. 1525). Studies have indicated that overnight fasting
increases the likelihood for PONV (Apfel, Meyer, Organ-Sungur, Jalota, Whelan, &
Jukar-Rao, 2012b). The frequent use of laparoscopic abdominal procedures poses another
safety concern (Yavux et al., 2014). In fact, patients have an increased incidence of 50%
to 80% for PONV after laparoscopic abdominal procedures because of Carbon Dioxide
(CO2) insufflation, nasogastric tube placement, and CO2 absorption (Blitz et al., 2012;
Yavux et al., 2014). In addition, another group of researchers determined that
laparoscopic procedures, gynecological surgery, and cholecystectomies are significant
predictors of PONV in themselves (Apfel et al., 2012a).
Researchers have identified preoperative fluid therapy as an effective and efficient
way to reduce the occurrence of PONV (Lambert et al., 2009). For example, one group of
researchers concluded that using fluid bolus as a preventive therapy is useful and cost
effective, and, in the future, could play a critical role in multimodal prevention (Magner,
McCaul, Carton, Gardiner, & Buggy, 2004). PONV can be costly to healthcare
organizations. Some of the increased cost of PONV involves more time spent in the
PACU and extended hospital care (Rahman & Beattie, 2008). However, not all patients
should receive preoperative fluid therapy. For instance, patients who have heart, kidney,
liver, respiratory, or brain conditions could experience negative effects if given to much
fluid (Adanir, Aksun, Ozgurbuz, Altin, & Sencan, 2008).
After speaking with seven CRNAs who are employed at the facility where this
DNP project will be implemented, they voiced that one out of five postoperative
assessments indicated patients suffered from PONV. They also voiced interest in learning
2

more ways to prevent this postoperative complication. Furthermore, 8 PACU (3 night
shift and 5 day shift) nurses were asked about their experience with PONV. The night
shift nurses reported having more patients with PONV than the day shift nurses.
However, the day shift nurse stated they still routinely treat patients experiencing PONV.
Clinical Question
The clinical question for this doctoral project is: Will CRNAs who have received
evidence-based information regarding preoperative fluid therapy as a method for
decreasing PONV make a practice change to incorporate it in their plan of care for
patients at high risk for developing PONV 2 weeks after receiving the information?
Preoperative fluid therapy before anesthesia generally will prevent a volume deficit,
therefore, facilitating a state of normovolemia (Yavux et al., 2014). The amount of
preoperative fluid therapy has varied among researchers. The most effective preoperative
fluid therapy ranges from crystalloids 5-30 ml/kg up to 1000 ml 1 hour prior to the
induction of anesthesia or some researchers replaced fluids using the 4-2-1 rule up to
1000 ml (Adanir et al., 2008; Ali et al., 2003; Apfel et al.,2012b; Chaudhary et al., 2008;
Ghafourifard et al., 2015; Lambert et al, 2009; Magner et al., 2004; Turkistani et al, 2009;
Yavux et al., 2014). Research findings have strongly supported the use of one to two
liters of crystalloids as a method to decrease drowsiness, dizziness, and PONV (Holte,
2010). Two other researchers found that patients who received 1000 ml crystalloids
preoperatively had less incidences of PONV than those patients who received less fluid
(2-3 ml/kg) (Monti & Porkorny, 1999). In CRNAs (P), will presenting an educational inservice (I) on the use of preoperative fluid therapy to decrease PONV in high risk
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populations effect their willingness to change practice (O) compared to CRNAs who do
not participate in the educational in-service (C) over the course of 2 weeks (T)?
Purpose of the Project
The primary purpose of this project was to create a practice change among
CRNAs in which they will incorporate preoperative fluid therapy to prevent PONV in at
risk patients for PONV. Providing information to CRNAs regarding the positive effects
of preoperative fluid therapy will heighten awareness of the need to incorporate this
therapy into their practice. By providing evidence-based information gained from the
literature review, CRNAs will be able to make an informed decision to use preoperative
fluid therapy in their plan of care.
Theoretical Framework
Since the primary purpose of this project is to create a practice change, the model
for evidence-based practice change will be used, which is a revised model from Melynk
and Fineout-Overholt (2015) model for evidence-based practice. The revised model could
serve as a foundation for many practice change projects. The revised model was based on
Rosswurm and Larrabee’s (1999) original model titled model for change to evidencebased practice.
The revised model consists of 6 steps. Step 1, evaluate if a change in practice is
warranted , involves as its name implies: (a) recognizing a practice problem; (b) seeking
ways to repair it; (c) gathering information that will improve possible interventions and
desired outcomes, such as comparing existing internal facts and statistics to present-day
practices to decipher if there is a problem; and (d) offering ways to repair problem and
goals that are to be achieved (Rosswurm & Larrabee, 1999; Melnyk & Fineout-Overholt,
4

2015). Step 2, locate the best evidence, involves several actions: (a) reviewing the
evidence to reveal the types and sources, (b) formulating a plan for the evidence search,
and (c) performing the search for the most accurate evidence (Larrabee, 2009). Step 3,
critically analyze the evidence, includes: (a) reviewing the evidence and concluding if the
evidence is strong or weak and (b) combining the chief evidence and discerning the
attainability, advantages, and negative outcomes of the new practice. Step 4, design the
practice change involves: (a) explaining the suggested practice change, (b) pinpointing
the resources that will be needed, (c) strategizing the appraisal of the pilot, and (d)
putting together the implementation plan. Step 5, implement and evaluate change in
practice, includes: (a) putting the pilot study into action; (b) accessing the process,
results, and expenses; and (c) formulating conclusions and suggestions for the future.
Step 6, integrate and maintain change in practice, involves: (a) disseminating the
information gathered about the new practice change with those persons it directly effects,
(b) include the new practice change as part of the standards of care, (c) tracking the
process and outcome indicators, and (d) sharing the outcomes of the project.
DNP Essentials
The DNP essentials (AACN, 2006) directly related to this doctoral project are
Essentials I, II, and VI (see Appendix A). DNP Essential I: Scientific Underpinnings for
Practice relates to this doctoral project in terms of the development of nursing science
through researching and adding to knowledge of preoperative fluid therapy use. DNP II
Essential: Clinical Scholarship and Analytical Methods for Evidence-Based Practice
relates to this doctoral project in terms of the use of clinical scholarship and evidencebased research that will enhance CRNA knowledge. DNP VI Essential: Interprofessional
5

Collaboration for Improving Patient and Population Health Outcomes relates to this
doctoral project by a collaboration with CRNAs to discuss the benefits of preoperative
fluid therapy use to decrease PONV to promote better patients’ post-anesthetic outcomes.
Summary of the Evidence
A literature review was conducted for this paper by initially accessing The
University of Southern Mississippi’s library website and utilizing the articles and
databases function. The selected databases included CINAHL, MEDLINE, and Health
Source: Nursing/Academic Edition. The phrase preoperative fluid therapy was entered in
the search field. There were 27 results, and 2 articles were relevant to the research topic.
Next, an advanced search was performed by using the advanced search option to look for
all search terms and not just phrases, including the terms PONV or postoperative nausea
and vomiting. The time frame was set for the last 10 to 20 years. This search yielded 10
articles; of the 10 articles, 2 were duplicates, 2 were irrelevant, and 6 articles were
relevant and, therefore, used. The other articles included in this paper were found by
citation tracking of the articles found in the previous mentioned search.
Postoperative Nausea and Vomiting
Nausea and vomiting are serious postoperative complications that significantly
decrease patients’ sense of well-being and are considered the most distressing byproduct
of general anesthesia and surgery (Chatterjee, Rudra, & Sengupta, 2011). Research has
revealed that 70% of patients experience PONV (Adanir, Aksun, Ozgurbuz, Altin, &
Sencan, 2008). Some patients even report worrying more about PONV than
postoperative pain (Rahman & Beattie, 2008). Negative effects associated with PONV
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include healthcare cost surge upward due to lengthened recovery room stays and
extended hospital care.
Many modalities have been implemented to help prevent these unfortunate
complications. For instance, many factors play into the cause of PONV. A variety of antinausea medications that work at different receptor sites should be used along with
utilizing a multimodal approach (Chatterjee et al., 2011). Ignoffo (2009) further reported
that using medications from various classes could be beneficial in treating those patients
at moderate risk for developing PONV. Adequate hydration is an essential part of a
multimodal approach (Adanir et al., 2008), especially since patients who have fasted after
midnight develop hypovolemia that can worsen PONV (Apfel et al., 2012a).
Several factors can lead to PONV, including the individual, specific medical
history, type of operation, and type of anesthetic used (Adanir et al., 2008). The Society
for Ambulatory Anesthesia (2014) listed adequate hydration as one of the strategies to
reduce PONV and include it in their consensus guidelines for the management of PONV
(Gan et al., 2014). PONV can be identified in high risk populations by using a
widespread PONV risk assessment tool known as the Simplified Apfel score (1999; see
Appendix B). The type of surgery is another documented contributing factor to the
development of PONV. For instance, the most notable post-surgery complication of
laparoscopic operations is PONV, which occurs in approximately 70% of patients
(Adanir et al., 2008). Laparoscopic surgery is believed to cause PONV due to pressure
exerted on the vagus nerve from insufflation of the abdomen (Chatterjee et al., 2011).
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Preoperative Fluid Therapy Mechanism of Action
The exact way in which preoperative fluid therapy decreases PONV remains
unclear (Adanir et al., 2008), but there are some reoccurring theories. Adanir et. al.
(2008) and Ali, Taguchi, Holtman, and Kurz (2003) discussed how patients fasting
overnight leads to hypovolemia, and if adequate fluid is not replaced, can cause PONV.
Lambert et. al. (2009) stated that every patient on the day of surgery is dehydrated from
fasting overnight. Another possible cause of PONV is serotonin release from gut mucosa
ischemia in response to perioperative hypo-perfusion; serotonin release is a powerful
stimulate of nausea and vomiting (Adanir et al., 2008).
Chaudhary, Sethi, Montiani, and Adatia (2008) also stated that temporary
intestinal ischemia can occur because of decreased perfusion to the mesentery caused by
fasting throughout the night coupled with the effects of anesthesia and fluids lost from
surgery. Giving patients’ fluids in advance improves perfusion to the mesentery thus
decreasing the chance of PONV. Adanir et al. (2008) emphasized that giving extra fluids
prior to inducing the patient can reduce the volume deficiency and improve splanchnic
perfusion; decreased perfusion to the intestines could be improved by adequate
splanchnic perfusion. Supplemental fluids given prior to inducing general anesthesia also
may cause the fluid volume status to normalize (Yavux et al., 2014).
Preoperative fluid therapy could also affect PONV through peripheral and central
mechanisms (Adanir et al., 2008). Dehydration most likely affects the chemoreceptor
trigger zone (CTZ). The CTZ is an area in the brain that has a vast amount of dopamine
and serotonin receptors. When these receptors are stimulated by endogenous
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catecholamines released due to anesthetics and surgery, PONV can occur (Rahman &
Beattie, 2008).
In a quantitative review, Apfel et. al. (2012b) suspected that antidiuretic hormone
(AVP) could increase the effect of additional fluids’ ability to decrease PONV. Their
belief stems from anesthesia causing arteries to dilate, creating a hypovolemic state. The
hypovolemic state causes a “reduced central venous pressure with reduced negative
feedback of the right atrial stretch receptors, leading to increased AVP release from the
posterior pituitary” (Apfel et al., 2012b, p. 4). AVP has been known to cause nausea and
vomiting (Apfel et. al., 2012b). For example, one group of researchers reported patients
who developed PONV had increased levels of AVP throughout surgery leading to
increased levels of AVP when brought to the recovery room; patients without PONV did
not have increased levels of AVP (Oddby-Muhrbeck et al., 2005).
Preoperative Fluid Therapy
A group of researchers conducted a prospective randomized control study on
three groups of 60 participants: Group A-- control group with a conservative amount of
Ringer’s lactate at 2 ml/kg Group B--Ringer’s lactate at 12 ml/kg; and (c) Group C--4.5%
hydroxyethlstarch at 12 ml/kg (Chaudhary et al., 2008). These researchers used a visual
analogue scale (VAS) to assess PONV. The results were as follows: Group A mean VAS
ranged from 0.45 to 4.30, Group B ranged from 0.25 to 3.90, and Group C ranged from
0.40 to 3.65. These researchers reported that the participants in Groups B and C
experienced lower mean VAS scores (p < 0.001) than the participants in the Group A,
who received conservative fluid therapy.
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Another group of researchers tested the benefit of preoperative fluid therapy in
female patients undergoing elective laparoscopic cholecystectomy. Group 1 received
Ringer’s lactate 15 ml/kg preoperatively, and Group 2 received Ringer’s lactate 2 ml/kg
preoperatively (Yavuz et. al., 2014). Total nausea VAS scores in Group 1 had a
significantly lower incidence of nausea at the 8th and 12th (p=0.001, p=0.041). Within the
range of 1 to 24 hours, Group 1 experienced less nausea and vomiting. They concluded
the patients in Group 1, who received a larger amount of fluid preoperatively,
experienced less PONV than the conservative fluid Group 2.
In a similar study, researchers tested two groups of patients undergoing
laparoscopic cholecystectomy and gynecological procedures (Ali et al., 2003). The
conservative fluid group received 2 ml/kg preoperatively and the supplemental fluid
group received 15 ml/kg preoperatively. The supplemental fluid group’s median
(interquartile range [range]) VAS for nausea was lower than the conservative fluid group.
The results were as follows: at 0 to 1 hour (16 (0-32[0-82]) vs. 0(0-10[0-70]),
respectively; p=0.013) and over the 1 to 24-hour study period (55(30-70[0-100] vs. 15(055[0-100]), respectively; p= 0.00).
A group of researchers conducted a prospective, double-blind, randomized,
control trial consisting of 210 patients and compared findings of two groups of patients
having laparoscopic cholecystectomies (Adanir et al., 2008). Group 1 received a
calculated volume deficit from overnight fasting along with a maintenance infusion of
0.9% normal saline at a rate of 1.5 ml/kg/hr intraoperatively. Group 2 received a
calculated volume deficit plus the same maintenance infusion preoperatively. The
findings demonstrated that in Group 1 64.42% of patients experienced nausea or
10

vomiting and retching. In Group 2, only 48.11% of patients experienced nausea or
vomiting and retching. When the two groups were compared in regards to patients that
received an antiemetic of nausea and vomiting, Groups 1 and 2 showed a statistically
significant difference (p=0.019).
In another study with similar results, researchers conducted a prospective,
randomized, control trail with 80 participants to compare four groups of patients
undergoing laparoscopic cholecystectomy (Turkistani et. al., 2009). Each group received
different fluids preoperatively. Group 1 received 10 ml/kg dose of low-MW tetrasrarch in
saline; Group 2 received 10 ml/kg of medium-MW penstarch in saline; Group 3 received
10 ml/kg of high-MW heta-starch; and Group 4 received 10ml/kg lactated ringers. Out of
the 4 groups, Group 4 experienced the least amount of PONV (30%). Thirty percent was
significantly less compared to the other groups (p < 0.05). At 24 hours, the incidence of
PONV was 5% in Group 1, 20% in Group 2, 20% in Group 3, and 15% in Group 4. The
incidence of PONV 2 hours after surgery was 5% in Group 4 compared to 35% in Group
1, 45% in Group 2, and 60% in Group 3 (p< 0.05).
Ghafourifard, Zirack, Broojerdi, Bayendor, and Moradi (2015) performed a
double-blinded, clinical trial involving 2 groups of 46 participants: (a) Group 1—the
crystalloid group received a 7 ml/kg preoperative bolus of Ringers solution and (b) Group
2—the colloid group received a 7 ml/kg preoperative bolus of 3% Haemaccel. They
concluded that both crystalloids and colloids help reduce the incidence of PONV. At 1
hour in the Ringer’s lactate group, the incidence of PONV was 18.52% and 14.82% in the
Haemeccel group.
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In another study, the researchers conducted a literature review on the incidence of
PONV (Apfel et al., 2012b). Fifteen trials were identified (N= 787 crystalloids; N= 783
conservative). They reported that “compared with conservative fluids, intravenous (IV)
crystalloids reduced the risk of early postoperative nausea (PON) (relative risk 0.73, 95%
confidence interval 0.59–0.89; p=0.003), late PON (0.41, 0.22–0.76; p=0.004), and
overall PON (0.66, 0.46–0.95; p=0.02). IV crystalloids did not reduce the risk of early
postoperative vomiting (POV) (0.66, 0.37–1.16; p=0.16) or late POV (0.52, 0.25–1.11;
p=0.09), but did reduce overall POV (0.48, 0.29–0.79; p=0.004). IV crystalloids did not
reduce the risk of early PONV (0.74, 0.49–1.12; p=0.16), but did reduce the risk of late
PONV (0.27, 0.13–0.54; p<0.001) and overall PONV (0.59, 0.42–0.84; p=0.003). IV
crystalloids reduced the need for antiemetic rescue treatment (0.56, 0.45–0.68; p<0.001)”
(Apfel et al., 2012b, p.1). Although IV crystalloids did not show to decrease early PONV,
they did decrease the risk of late PONV and overall PONV.
The next four studies reflected similar findings as the previously mentioned
studies. All four studies included women undergoing laparoscopic gynecological
procedures. Lambert et. al.’s (2009) controlled, prospective blinded study of 46
participants consisted of 2 groups: (a) Group 1, whom received up to 1 liter of lactated
ringers preoperatively using the 4-2-1 rule as a guide and (b) Group 2, whose fluids were
replaced at the time decided by the provider. Of the 16 patients in this study who
experienced PONV, 5 patients from Group 1 experienced episodes of nausea. Eleven
patients from Group 2 experienced episodes of nausea and 1 vomiting episode. Therefore,
Group 1 had a 22% occurrence of PONV compared to Group 2’s 52% occurrence of
PONV.
12

Magner et al. (2004) conducted a prospective, randomized, double-blinded trial
consisting of 141 female participants that produced similar findings to Lambert et. al.’s
study. This study also consisted of 2 groups: (a) Group 1, who received compound
sodium lactate at a rate of 10 ml/kg starting in the preoperative period and (b) Group 2,
who received compound sodium lactate at a rate of 30 ml/kg starting in the preoperative
period. They noted that Group 1 had a lower incidence of vomiting in the first 48 hours
compared to Group 2 (8.6% vs. 25.7%, p=0.01). Also, Group 1 required less anti-emetic
administration than Group 2 at 0.5 hours (2.9% vs. 14.3%, p=0.04). Group 1 experienced
significantly less severe nausea than Group 2 upon awakening (2.9% vs. 15.7%, p=0.02),
2 hours (0.0% vs. 8.6%, p=0.04) and cumulatively (5.7% vs. 27.1%, p=0.001).
Maharaj et. al. (2005) tested 2 groups consisting of 80 women presenting for
laparoscopic gynecological surgery: (a) the large volume group, who received compound
sodium lactate at 2 ml/kg per hour of fasting and (b) the control group, who received the
same fluid at 3 ml/kg (not per hour of fasting). In the first 72 hours postoperatively, the
overall occurrence of PONV was significantly less in Group 1 (59%) versus Group 2
(87%) (p <0.05). Also, mean postoperative VAS scores were significantly less in Group 1
(p < 0.05) in the PACU, and at 1, 4, 24, and 72 hours postoperatively. The large volume
group experienced less incidence of PONV.
Monti and Pokorny (1999) studied 2 groups of patients consisting of 90 women
undergoing laparoscopic gynecological surgery: (a) the experimental group, who received
a 1 liter fluid bolus preoperatively and (b) the control group, who received fluids based
on provider discretion. In the control group, 30% of patients experienced nausea and 5%
experienced vomiting. Regarding nausea and vomiting, a significant difference was noted
13

between the 2 groups (p= .001). A total of 51% of the patients in the control group
experienced nausea and vomiting compared to only 17% experiencing nausea and
vomiting in the experimental group. The findings were consistent with the previous three
studies that preoperative fluid therapy decreases PONV in gynecological laparoscopic
procedures.
Conclusion
Evidence suggest that preoperative fluid therapy is an effective way to reduce
PONV and, therefore, should be considered in the treatment plan of those individuals
who are at increased risk for developing PONV. Patients at increased risk of developing
PONV need to first be identified by way of an assessment. The Simplified Apfel score
(1999) is a useful tool in identifying those patients at increased risk of developing PONV.
This score lists four characteristics: (a) female gender, (b) non-smoker, (c) history of
PONV, and (d) postoperative opioids. Even if no risk characteristics are present, the
patient is still at a 10% risk of developing PONV; the chance that a patient will develop
PONV rises to 20%, 40%, 60%, and 80% for each added risk factor (Apfel et al., 1999;
Gan et al., 2014).
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CHAPTER II - METHODOLOGY
Evidence indicated that preoperative fluid therapy is an effective part of a
multimodal approach to decrease postoperative nausea and vomiting (PONV).
Furthermore, the use of preoperative fluid therapy can easily be incorporated into the
anesthesia plan. The aim of this project was to create a practice change in which Certified
Registered Nurse Anesthetists (CRNAs) incorporate preoperative fluid therapy into their
plan of care in those patients who are at increased risk of developing PONV.
Setting and Target Population
The target population for this project consisted of fully licensed CRNAs at a 512bed hospital in South Mississippi. There was a total of 40 CRNAs at this facility.
Therefore, there could have been up to 40 participants. These CRNAs were chosen as a
convenience sample because of their location and their rapport with this student
registered nurse anesthetist (SRNA) Also, the informal needs assessment revealed that
CRNAs and post-anesthesia care unit (PACU) nurses were still treating patients for
PONV.
Design
An educational in-service for the CRNAs was held at the chosen facility. The
educational in-service was related to incorporating preoperative fluid therapy into their
plan of care to decrease PONV and consisted of knowledge gathered from information in
the literature review. After the in-service, the CRNAs will be asked to incorporate
preoperative fluid therapy in their plan of care over the next 2 weeks. During those 2
weeks, the CRNAs were asked to document how many times they used preoperative fluid
therapy. They were asked to document the number of times in their cellular device.
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The CRNAs were presented with two questionnaires (see Appendix C). They
completed the first questionnaire on the day of the in-service education. This first
questionnaire consisted of five items, three of which related to demographic data (age,
years of experience, and gender), one related to their knowledge of the Simplified Apfel
score, and one related to their use of preoperative fluid therapy. The second questionnaire
was presented at the end of the 2 weeks and asked if the CRNAs did or would make a
practice change based on their implementation of preoperative fluid therapy the last 2
weeks and based on evidence-based information presented to them in the educational inservice. The second questionnaire inquired about any barriers the CRNAs experienced
when utilizing preoperative fluid therapy in their plan of care, if the in-service influenced
their decision to use preoperative fluid therapy in their plan of care, and if they have any
additional comments.
Procedures
Approval was secured from the Institutional Review Board (IRB) of The
University of Southern Mississippi (Protocol number 17080701) (see Appendix D) and
approval from the facility was obtained before any data collection or implementation of
the project (see Appendix E). Descriptive statistics determined the percentage of CRNAs
who have changed their practice to incorporate preoperative fluid therapy in their plan of
care. The Simplified Apfel score was utilized in the in-service to facilitate the CRNAs’
ability to recognize those patients at increased risk of developing PONV.
Ethical Protection of Human Subjects (IRB)
This project was submitted for approval to The University of Southern
Mississippi. Approval for the doctoral project was obtained from the facility. All
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information in terms of the educational in-service, discussions within the in-service, and
data collected was kept confidential and secure. This SRNA assured confidentiality to the
participants before they signed the consent form. Anonymity was maintained and assured
regarding the information collected on the questionnaires. Data will be disseminated in a
collective manner so as not to point out or identify any person. All data collected related
to this project was securely maintained and then will be destroyed 6 months after
graduation. Although anonymity was maintained in terms of the questionnaires and data
collected from them, anonymity was not completely possible for the in-service
participation because of the nature of the in-service. This SRNA asked the participants to
maintain confidentiality and anonymity when they leave the in-service. There were no
anticipated risks to the CRNAs for participation.
Resource Requirements
The resources required to fulfill this research project was the CRNA staff,
questionnaires for the CRNAs, and time needed for the in-service. Also, the CRNAs
needed easy access to the crystalloids. The in-service took approximately 10 to 15
minutes. Administering fluids preoperatively also took additional time from the CRNAs.
The time needed to administer the fluids was approximately 15 minutes. Because of the
busy schedule of the CRNAs, the in-services were conducted in small groups. An area
conducive to learning was designated at the facility for the in-service.
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CHAPTER III – RESULTS
Data Analysis
Descriptive statistics was utilized for data analysis. The independent variables for
this study included the educational in-service, and demographic information which
included: gender, age, and years of experience. The dependent variable was the mean
score of the use of preoperative fluid therapy from questionnaire II collected 2 weeks
after the educational in-service.
Results
A total of 18 Certified Registered Nurse Anesthetists (CRNAs) consented to
participate in this study. Before the educational in-service was given, each CRNA
completed questionnaire I. Next, the CRNAs were presented the educational in-service
and given an opportunity to ask questions. Questionnaire I was used to obtain
demographic information, assess the CRNAs knowledge on how to recognize high risk
patients, and assess if they currently used preoperative fluid therapy to decrease
postoperative nausea and vomiting (PONV). The following information was obtained
from questionnaire I. The majority of participants in this project were males (83%, n=15).
There were four age groups: (a) 25-35 years old (33.3%, n=6), (b) 35-45 years old
(33.3%, n=6), (c) 45-55 years old (22.2%, n=4), and (d) 55 or older (11.1%, n=2) (see
Figure 1). Years of experience was divided into 4 categories: (a) 0-5 years (33.3%, n=6),
(b) 6-10 years (16.7%, n=3), (c) 11-15 years (11.1%, n=2), and (d) 15 years or more
experience (38.9%, n=7) (see Figure 2). For the question, “are you familiar with the
Simplified Apfel score?”, 94.4% (n=17) said no and only 5.6% (n=1) said yes. For the
question, “do you currently use preoperative fluid therapy in your plan of care to decrease
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PONV?”, 72.2% (n=13) said no and 27.8% (n=5) said yes. The mean value of CRNAs
who currently use preoperative fluid therapy in there plan of care was 0.28.

Figure 1. Participants age category

Figure 2. Participants years of experience
Two weeks after the educational in-service and questionnaire I, the CRNAs were
asked to answer questionnaire II. The following information was obtained from
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questionnaire II. For the question, “how many times did you use preoperative fluid
therapy as part of your plan of care?”, participants could choose 3 different options: (a) 15 times (38.9%, n=7), (b) 6-10 times (50%, n=9), and (c) 10 or more times (11.1%, n=2).
On the second question on questionnaire II, “were there any barriers that prevented them
from using preoperative fluid therapy?”, the majority (66.7%, n=12) said no. Three
CRNAs (16.6%) listed time constraints as being a barrier. Three CRNAs (16.6%) said
patients’ comorbidities interfered with their ability to include preoperative fluid therapy
in their plan of care for all patients. On the last question of questionnaire II, “did the
educational in-service influence your decision to use preoperative fluid therapy?”, 100%
(n=18) of the participants answered yes. In the section for additional comments, one
CRNA stated, “Very informative. Definitely will influence my anesthetic technique.” The
mean value of CRNAs who used preoperative fluid therapy in their plan of care after the
in-service was 1.
The project’s intervention was a 10- to 15-minute educational in-service on the
use of preoperative fluid therapy to decrease PONV in high risk populations. The inservice consisted of an educational handout (see Appendix F) on how to recognize
patients at increased risk of developing PONV (Simplified Apfel score) and preoperative
fluid therapy mechanism of action as well as administration. There were 18 CRNAs who
consented to participate in the educational in-service and questionnaires I and II were
collected from all 18 participants. Questionnaire I was collected the day of the in-service
and questionnaire II was collected 2 weeks later.

20

CHAPTER IV – DISCUSSION
Interpretation of Results
The information gained from questionnaire I revealed a knowledge deficit. Of the
participants, 94.4% (n=17) were not familiar with the Simplified Apfel score. This score
identifies people at increased risk of developing postoperative nausea and vomiting
(PONV). Part of the in-service consisted of a detailed discussion on the score and how to
use it. Questionnaire I revealed that only 27.8% (n=5) were currently using preoperative
fluid therapy in their plan of care. The in-service provided information from the literature
review regarding the use of preoperative fluid therapy to decrease PONV to the Certified
Registered Nurse Anesthetists (CRNAs). Of the CRNAs’ responses on questionnaire II,
100% reported they used preoperative fluid therapy to some extent in their plan of care
over the 2-week time frame. This finding indicated a 72.2% increase in CRNAs use of
preoperative fluid therapy in their plan of care. Furthermore, 100% of participants agreed
the educational in-service did influence their decision to use preoperative fluid therapy.
The mean value of CRNAs that utilized preoperative fluid therapy increased from 0.28 to
1 after participating in the in the educational in-service.
The primary purpose of this project was to create a practice change for CRNAs to
incorporate preoperative fluid therapy to prevent PONV in at risk patients for PONV. The
primary goal of this project was fulfilled; namely, a 72.2% increase in the use of
preoperative fluid therapy and 100% of CRNAs selected yes to the question, “did the
educational in-service influence your decision to use preoperative fluid therapy?”

21

Limitations
Limitations of this project included the inability to eliminate bias because of the
nature of this project’s convenience sample, which means that participants will meet the
candidate requirements for the study (Melnyk & Fineout-Overholt, 2015). Another
limitation was the small sample size. Only 18 of 40 CRNAs at this facility participated in
the study because of variation in the daily CRNA scheduling at this facility.
Future Practice Implications
Continuing education on evidence-based practices is important in medical and
nursing professions to provide the best care for patients. Offering educational in-services
to CRNAs is one way to help them keep current on best practices and recognize
knowledge deficits. Educational in-services are also a good way to refresh concepts and
generate new practices. CRNA students are in a unique position to offer seasoned
CRNAs the most current literature regarding best practices.
Conclusion
The 18 CRNA participants indicated on questionnaire II that the educational inservice influenced their decision to use preoperative fluid therapy in their plan of care.
Furthermore, 100% of the CRNA participants used preoperative fluid therapy to some
extent over the 2-week time frame after they participated in the educational in-service, as
compared to only 27.8% before the in-service. The PICO question for this project is: In
CRNAs (P), will presenting an educational in-service (I) on the use of preoperative fluid
therapy to decrease PONV in high risk populations effect their willingness to change
practice (O) compared to CRNAs who do not participate in the educational in-service (C)
over the course of 2 weeks (T). The results of this study confirm that the answer to this
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PICO question is yes. The results and knowledge gained from this project can be shared
with other anesthesia providers through presentations and at related conferences.
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APPENDIX A – DNP Essentials
Table A1.
DNP Essentials
I. Scientific Underpinnings for Practice

relates to this doctoral project in terms of the
development of nursing science through
researching and adding to knowledge of
preoperative fluid therapy use
relates to this doctoral project in terms of the use
of clinical scholarship and evidence-based
research that will enhance CRNA knowledge

II. Organizational and Systems Leadership for
Quality Improvement and System Thinking
III. Clinical Scholarship and Analytical Methods
for Evidence-Based Practice
IV. Information Systems/Technology and Patient
Care Technology for the Improvement and
Transformation of Health Care
V. Health Care Policy for Advocacy in Health Care
VI. Interprofessional Collaboration for Improving
Patient and Population Health Outcomes

VII. Clinical Prevention and Population Health for
Improving the Nation’s Health
VIII. Advanced Nursing Practice
(AACN, 2006)
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relates to this doctoral project by a collaboration
with CRNAs to discuss the benefits of
preoperative fluid therapy use to decrease PONV
to promote better patients’ post-anesthetic
outcomes.

APPENDIX B - Simplified Apfel Score
Table A2.
Simplified Apfel Score
Risk Factors

Points

Female Gender

1

Non-Smoker

1

History of PONV

1

Postoperative Opioids

1

Sum =

0…4

(Apefel et al., 1999; Gan et al., 2014)

Table A3.
Simplified Apfel Score

PONV Risk

90%
80%
70%
60%

0

50%

1

40%

2

30%

3

20%

4

10%
0%

# of Risk Factors
(Apfel et al., 1999; Gan et al., 2014)
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APPENDIX C - Questionnaires
Questionnaire I
1) How long have you been a Certified Registered Nurse Anesthetist?
a) 0-5 years
b) 6-10 years
c) 11-15 years
d) >15 years
2) What is your gender?
a) Male
b) Female
3) What is your age category?
a) 25-35 years old
b) 35-45 years old
c) 45-55 years old
d) >55 years old
4) Are you familiar with the Simplified Apfel score?
a) Yes
b) No
5) Do you currently use preoperative fluid therapy in your plan of care to decrease
PONV?
a) Yes
b) No
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Questionnaire II
1) How many times did you use preoperative fluid therapy as part of your plan of
care?
a) 1-5 times
b) 6-10 times
c) >10 times

2) Were there any barriers that prevented you from using preoperative fluid therapy?

3) Did the educational in-service influence your decision to use preoperative fluid
therapy?
a) Yes
b) No

Additional Comments:
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APPENDIX D - IRB Approval Letter
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APPENDIX E - Letter of Support
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APPENDIX F – Educational In-service Handout

Educational In-service
Background and Significance
•

PONV still occurs in up to 25%-30% of all surgeries and up to 70% in high risk
populations.
(Lambert et al.,2009)

•

PONV has been linked to negative complications such as extra time spent in the
post-anesthesia care unit (PACU), extended patient stay, patient discontent,
increased hospital expenses, and morbidity.
(Lambert et al., 2009)

•

The Society for Ambulatory Anesthesia (2014) lists adequate hydration as one of
the strategies to help reduce PONV, and, include it in their consensus guidelines
for the management of PONV.
(Gan et al., 2014)

Recognizing High Risk Populations
•

The Simplified Apfel Score (1999) is a useful tool in identifying those patients at
increased risk of developing PONV.

•

The score lists four characteristics: (a) female gender, (b) non-smoker, (c) history
of PONV, and (d) postoperative opioids.
(Apfel et al., 1999)

•

Even if no risk characteristics are present, the patient is still at a 10% chance of
developing PONV; the possibility of developing PONV rises to 20%, 40%, 60%,
and 80% for each added risk factor.
(Apfel et al., 1999; Gan et al., 2014)

•

The type of surgery has been shown to effect PONV; laparoscopic abdominal
surgeries and gynecological procedures carry a greater risk of the patient
developing PONV.
(Apfel et al., 2012a; Blitz et al., 2012; Yavux et al., 2014)
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•

The length of the procedure and the use of volatile anesthetics are significant
indicators for the development of PONV.
(Apfel et al., 2012a; Chatterjee, 2011)
Risk Factors

Points

Female Gender

1

Non-Smoker

1

History of PONV

1

Postoperative Opioids

1
0…4

Sum =

(Apfel et al., 1999; Gan et al., 2014)

Mechanism of Action
•

The exact way in which preoperative fluid therapy decreases PONV remains
unclear.
(Adanir et al., 2008; Yavux et al., 2014)

•

Reoccurring theories suggest:
o Anesthesia agents create a state of hypovolemia leading to
hypoperfusion that causes the release of endogenous catecholamines
such as dopamine and serotonin.
o The hypovolemic state generated by anesthesia agents causes
antidiuretic hormone (ADH) to be released from the posterior pituitary
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gland; studies have shown that patients with increased levels of ADH
experience more episodes of PONV.
(Adanir et al., 2008; Chaudhary et al., 2008; Yavux et al., 2014)

Fluid Therapy
•

After reviewing the literature, the dosage ranged from 5-30ml/kg up to 1 liter of
crystalloids approximately 1 hour before anesthesia induction.
(Adanir et al., 2008; Ali et al., 2003; Apfel et al., 2012b; Chaudhary et al.,
2008; Ghafourifard et al., 2015; Lambert et al., 2009; Magner et al., 2004;
Turkistani et al., 2009; Yavux et al., 2014)

•

In one study, the crystalloids were given using the 4-2-1 rule up to 1 liter of fluid
while other studies gave 1-2 liters of crystalloids preoperatively at the discretion
of the anesthesia provider.
(Lambert et al., 2009)

•

Not all patients are candidates for preoperative fluid therapy; patients with heart
(CHF), Kidney (ESRD on dialysis), liver, respiratory, or neurologic conditions could
experience adverse effects from excess fluids.
(Adanir et al., 2008)
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